Brief: Altimmune Q1 Net Income USD -19.575 Million
May 13 (Reuters) - Altimmune Inc ALT.O: ALTIMMUNE Q1 NET INCOME USD -19.575 MILLION VERSUS. IBES ESTIMATE USD -26 MILLION ALTIMMUNE Q1 BASIC EPS USD -0.26 ALTIMMUNE Q1 OPERATING EXPENSES USD 21.82 MILLION ALTIMMUNE Q1 INCOME FROM OPERATIONS USD -21.815 MILLION VERSUS. IBES ESTIMATE USD -27.4 MILLION ALTIMMUNE Q1 REVENUE USD 5 THOUSAND VERSUS. IBES ESTIMATE USD 0 Source text: ID:nGNX7l2k6P Further company coverage: ALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altimmune
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial (updated)